Jefferies initiates coverage of Teradyne with a Buy rating and $284 price target

Jefferies began covering Teradyne, assigning a Buy rating and a $284 price target after the company reported third‑quarter 2026 results that beat expectations. The broker highlighted the firm’s shift toward AI‑driven chip testing and expects its share of the system‑on‑chip test market to rise, potentially boosting revenue to several billions. The note also projects a sizable revenue stream from Nvidia contracts by the end of 2029. Following the release, Teradyne’s shares jumped roughly 8% to $265.78.

The new rating and target could attract investors, providing a catalyst for the stock after a steep decline; Jefferies’ forecast of higher market share and Nvidia‑related revenue suggests future earnings upside. The price target of $284 is about 7% above the closing price, offering a near‑term upside potential.

  • 1Jefferies initiated coverage with a Buy rating and a $284 price target.
  • 2Teradyne’s shares rose 8.3% to $265.78 after the note was released.
  • 3Third‑quarter 2026 revenue was $1,306 million, up 70% year over year.
  • 4Adjusted earnings for Q3 2026 were $2.29 per share.
  • 5AI‑related revenue in Q3 2026 was about $500 million.
  • 6Jefferies expects the automated test equipment market to expand from roughly $9 billion in 2025 to about $25 billion by 2030.

Sources